John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
NEW YORK, April 7, 2016 -- AlixPartners, the global advisory firm, today announced that Matthew Evans has joined as a Managing Director in the firm's Financial Advisory Services practice. Mr. Evans brings extensive experience in the global commodities and derivatives markets, valuation, trading, risk management practices, and hedging. He will be based in the New York office and will work closely with the firm's team in Washington, DC.
Mr. Evans' experience includes litigation support in many high-profile commodity cases; providing expert testimony on commodities, derivatives, and high-frequency trading; and serving as an expert in over a dozen major market manipulation inquiries, regulatory enforcement actions, and trading investigations. He has presented findings to regulators in inquiries and enforcement actions brought by the SEC, FERC, CFTC, DOJ, FCA, and the European Commission.
"Matt brings to our clients a strong blend of financial and regulatory expertise," said Simon Freakley, Chief Executive Officer of AlixPartners. "His background and credibility strengthen AlixPartners' financial investigative services offering and deepens our expertise in key areas of regulatory scrutiny. We are delighted to welcome him to the firm."
At AlixPartners, Mr. Evans will work closely with clients in need of assistance with complex trading data issues, regulatory investigations in financial markets, disputes in commodities and derivatives markets, and litigation support in financial market cases.
Mr. Evans joins AlixPartners from NERA Economic Consulting where he served as Senior Vice President in the New York office. Prior to NERA, Mr. Evans was a Director at Barclays Capital, where he was Head of US Commodities Valuations and New Business.
Mr. Evans holds an undergraduate degree in International Business from Ithaca College.
About AlixPartners
AlixPartners is a leading global business-advisory firm of results-oriented professionals who specialize in creating value and restoring performance. We thrive on our ability to make a difference in high-impact situations and to deliver sustainable, bottom-line results. The firm's expertise covers a wide range of businesses and industries whether they are healthy, challenged or distressed. Since 1981, we have taken a unique, small-team, action-oriented approach to helping corporate boards and management, law firms, investment banks and investors to respond to crucial business issues. For more information, visit www.alixpartners.com.
CONTACT: Megan Bengoechea
+1 347 821 0167
[email protected]
